翻訳と辞書 |
zanolimumab
Zanolimumab (expected trade name HuMax-CD4〔(Genmab initiates Phase II Study with HuMax-CD4 )〕) is a human monoclonal antibody and an immunosuppressive drug. It is being developed for the treatment of rheumatoid arthritis, psoriasis, melanoma,〔http://www.tenxbiopharma.com/development.shtml〕 cutaneous and peripheral T-cell lymphoma.〔(Statement On A Nonproprietary Name Adopted By The USAN Council - Zanolimumab ), ''American Medical Association''.〕 The drug is currently undergoing Phase II trials.〔(【引用サイトリンク】url=http://clinicaltrials.gov/search/intervention=Zanolimumab )〕 == References == 〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「zanolimumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|